These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders. Semenzato G; Calabretto G; Teramo A; Gasparini VR; Rampazzo E; Barilà G; Zambello R Blood Cancer J; 2024 Jan; 14(1):13. PubMed ID: 38238319 [TBL] [Abstract][Full Text] [Related]
11. [Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review]. Qiu ZY; Fan Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):254-60. PubMed ID: 26913432 [TBL] [Abstract][Full Text] [Related]
12. STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia. Shi M; He R; Feldman AL; Viswanatha DS; Jevremovic D; Chen D; Morice WG Hum Pathol; 2018 Mar; 73():74-81. PubMed ID: 29288042 [TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of sensitive and quantitative STAT3 mutation analysis using next-generation sequencing in T-cell large granular lymphocytic leukemia. Kristensen T; Larsen M; Rewes A; Frederiksen H; Thomassen M; Møller MB J Mol Diagn; 2014 Jul; 16(4):382-92. PubMed ID: 24797340 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of flow cytometric T cell receptor Vβ repertoire and T cell receptor gene rearrangement in the diagnosis of large granular lymphocytic lymphoproliferation. Hsieh YC; Chang ST; Huang WT; Kuo SY; Chiang TA; Chuang SS Int J Lab Hematol; 2013 Oct; 35(5):501-9. PubMed ID: 23286298 [TBL] [Abstract][Full Text] [Related]
16. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations. Rajala HL; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S Ann Med; 2014 May; 46(3):114-22. PubMed ID: 24512550 [TBL] [Abstract][Full Text] [Related]
17. Familial CD3+ T large granular lymphocyte leukemia: evidence that genetic predisposition and antigen selection promote clonal cytotoxic T-cell responses. Stalika E; Papalexandri A; Iskas M; Stavroyianni N; Kanellis G; Kotta K; Pontikoglou C; Siorenta A; Anagnostopoulos A; Papadaki H; Papadaki T; Stamatopoulos K Leuk Lymphoma; 2014 Aug; 55(8):1781-7. PubMed ID: 24180333 [TBL] [Abstract][Full Text] [Related]